| Literature DB >> 33066554 |
Hyeyun Kim1, Bong Jin Jang2, A Ram Jung3, Jayoung Kim4, Hyo Jin Ju5, Yeong In Kim1.
Abstract
Background and objectives: A time-restricted diet is one of the various ways to improve metabolic condition and weight control. However, until now, there have been few pieces of evidence and research to verify the methods and effectiveness of time-restricted diets on metabolic improvement and health promoting. We designed this study to make a healthy diet program and to verify the effectiveness of a time-restricted diet on general health, including sleep and metabolism, in healthy volunteers. Materials andEntities:
Keywords: metabolism; sleep; time-restricted diet
Mesh:
Year: 2020 PMID: 33066554 PMCID: PMC7602198 DOI: 10.3390/medicina56100540
Source DB: PubMed Journal: Medicina (Kaunas) ISSN: 1010-660X Impact factor: 2.430
Dietary compositions.
| Nutrition Composition (g) | % kcal | |||||
|---|---|---|---|---|---|---|
| Carbohydrate | Protein | Fat | Carbohydrate | Protein | Fat | |
| 1, 2 weeks | 26.8 | 88.5 | 90.1 | 8 | 28 | 64 |
| 3 weeks | 32.5 | 90.6 | 97.6 | 9 | 26 | 65 |
| 4 weeks | 65.4 | 85.2 | 90.0 | 18 | 24 | 58 |
Figure 1Example of lunch boxes. (A) Smoked salmon steak, cherry tomato, grilled tofu, black sesame dressing and bellflower salad. (B) Pork meat, stir-fried bracken, lettuce sesame leaf salad, and steamed cabbage.
Basic characteristics of participants (n = 15).
| Before Program | After Program |
| |
|---|---|---|---|
| Body weight (kg) | 82.0 ± 15.6 | 78.2 ± 14.1 | 0.539 |
| Body Mass Index (kg/m2) | 29.3 ± 4.6 | 27.9 ± 3.8 | 0.233 |
| Body fat mass (kg) | 29.5 ± 8.7 | 26.1 ± 7.6 | 0.285 |
| Body muscle mass (kg) | 29.4 ± 7.1 | 29.0 ± 6.8 | 0.870 |
Figure 2Ketone changes between high- and low-ketone group. Participants were divided into high-ketone groups that exceeded 1 mmol/L and low-ketone group that did not exceeded 1 mmol/L.
Metabolic changes between high/low-ketone groups (n = 15).
| Low Ketone Group ( | High Ketone Group ( |
| |||
|---|---|---|---|---|---|
| Before | After | Before | After | ||
| Body weight (kg) | 75.23 ± 75.14 | 73.90 ± 14.66 | 86.43 ± 15.03 | 81.13 ± 13.71 | 0.006 |
| Body Mass Index (kg/m2) | 27.33 ± 1.64 | 26.93 ± 1.90 | 30.61 ± 5.56 | 28.62 ± 4.71 | 0.008 |
| Body fat mass (kg) | 28.40 ± 2.42 | 27.22 ± 2.71 | 30.20 ± 11.23 | 25.42 ± 9.69 | 0.007 |
| Body muscle mass (kg) | 25.83 ± 8.70 | 25.65 ± 8.06 | 31.76 ± 4.98 | 31.29 ± 5.03 | 0.522 |
Changes in serologic variables between high/low-ketone groups (n = 15).
| Low Ketone Group ( | High Ketone Group ( |
| |||
|---|---|---|---|---|---|
| Before | After | Before | After | ||
| AST | 20.50 ± 3.45 | 23.00 ± 6.23 | 31.11 ± 16.10 | 31.89 ± 19.19 | 0.600 |
| ALT | 19.83 ± 9.41 | 20.17 ± 7.22 | 62.33 ± 75.22 | 45.33 ± 47.42 | 0.192 |
| BUN | 11.55 ± 3.16 | 12.50 ± 4.61 | 14.74 ± 2.88 | 14.27 ± 2.79 | 0.521 |
| Creatine | 0.56 ± 0.10 | 0.58 ± 0.11 | 0.76 ± 0.15 | 0.83 ± 0.16 | 0.223 |
| γ-GTP | 35.00 ± 13.60 | 24.00 ± 10.77 | 42.67 ± 34.44 | 19.89 ± 13.60 | 0.257 |
| ALP | 69.17 ± 20.17 | 70.17 ± 15.68 | 63.78 ± 15.68 | 66.22 ± 18.55 | 0.803 |
| Total Cholesterol | 173.33 ± 31.94 | 169.17 ± 21.10 | 186.22 ± 33.46 | 180.56 ± 45.36 | 0.910 |
| LDL Cholesterol | 105.00 ± 24.23 | 99.67 ± 16.08 | 116.89 ± 25.30 | 110.44 ± 32.01 | 0.909 |
| TG | 119.50 ± 55.39 | 129.33 ± 73.55 | 153.67 ± 67.54 | 172.89 ± 231.20 | 0.934 |
| Glucose | 95.67 ± 29.04 | 104.33 ± 5.99 | 115.56 ± 45.12 | 96.33 ± 8.03 | 0.175 |
| Insulin | 8.70 ± 1.72 | 8.08 ± 1.31 | 15.37 ± 5.53 | 8.14 ± 5.53 | 0.006 |
| HOMA IR | 2.27 ± 0.58 | 2.09 ± 0.42 | 4.79 ± 3.98 | 2.00 ± 1.49 | 0.052 |
AST—Aspartate transaminase; ALT—Alanine transaminase; BUN—Blood urine nitrogen; r-GTP—Gamma Glutamyl Transpeptidase; ALP—Alkaline phosphatase; TG—Triglyceride; HOMA-IR—Homeostatic Model Assessment for Insulin Resistance.
Questionnaire results before and after high/low-ketone group (n = 15).
| Low Ketone Group ( | High Ketone Group ( |
| |||
|---|---|---|---|---|---|
| Variables | Before | After | Before | After | |
| PSQI-K 1 | 8.00 ± 3.46 | 6.50 ± 1.22 | 7.11 ± 2.37 | 5.11 ± 0.78 | 0.759 |
| STOP BANG | 2.50 ± 1.64 | 2.50 ± 1.64 | 3.00 ± 1.00 | 3.00 ± 1.00 | - |
| SSS 2 | 2.17 ± 0.98 | 2.83 ± 1.17 | 2.56 ± 0.23 | 2.67 ± 0.50 | 0.256 |
| ESS 3 | 9.00 ± 3.46 | 10.00 ± 2.19 | 9.11 ± 4.59 | 8.89 ± 4.91 | 0.465 |
| HADS 4 Anxiety | 4.67 ± 2.34 | 6.33 ± 3.93 | 6.78 ± 2.54 | 6.44 ± 2.55 | 0.225 |
| HADS Depression | 3.33 ± 1.86 | 4.50 ± 1.38 | 4.67 ± 3.32 | 4.11 ± 2.37 | 0.082 |
| ISI 5 | 6.17 ± 3.87 | 5.00 ± 1.41 | 7.75 ± 1.83 | 5.38 ± 2.97 | 0.529 |
1 Pittsburg Sleep Quality Scale-K, 2 Stanford Sleepiness Scale, 3 Epworth Sleepiness Scale, 4 Hospital Anxiety and Depression Scale, 5 Insomnia Severity Index.
Polysomnographic findings between the high/low-ketone groups (n = 15).
| Low Ketone Group ( | High Ketone Group ( |
| |||
|---|---|---|---|---|---|
| Before | After | Before | After | ||
| Total Sleep Time (min) | 425.53 ± 37.96 | 415.32 ± 97.12 | 428.39 ± 51.76 | 442.87 ± 42.44 | 0.547 |
| Latency to sleep onset | 11.30 ± 3.91 | 27.02 ± 21.57 | 28.23 ± 34.01 | 27.61 ± 31.93 | 0.295 |
| Latency to REM onset | 90.03 ± 30.02 | 81.82 ± 52.77 | 148.90 ± 129.27 | 69.80 ± 61.56 | 0.220 |
| Sleep Efficiency (%) | 90.40 ± 7.57 | 89.17 ± 6.19 | 89.09 ± 8.99 | 86.50 ± 6.07 | 0.776 |
| Sleep stage N1 (%) | 1.80 ± 0.49 | 1.48 ± 0.33 | 3.49 ± 4.49 | 2.63 ± 1.26 | 0.775 |
| Sleep stage N2 (%) | 54.23 ± 8.97 | 52.83 ± 10.90 | 59.92 ± 13.38 | 55.50 ± 6.49 | 0.683 |
| Sleep stage N3 (%) | 19.73 ± 8.35 | 21.42 ± 5.80 | 15.51 ± 3.91 | 19.09 ± 8.67 | 0.699 |
| Sleep stage REM (%) | 24.25 ± 3.69 | 24.27 ± 5.65 | 21.10 ± 10.00 | 22.57 ± 5.41 | 0.745 |
| Wake After Sleep Onset | 45.40 ± 41.60 | 44.92 ± 35.97 | 51.56 ± 42.63 | 69.54 ± 41.63 | 0.472 |
| AHI | 9.05 ± 5.78 | 9.02 ± 7.13 | 25.27 ± 12.67 | 15.11 ± 11.50 | 0.025 |
| PLMSi | 4.78 ± 7.86 | 2.85 ± 5.28 | 30.90 ± 49.32 | 19.57 ± 44.70 | 0.752 |
| Oxygen desaturation index | 4.07 ± 3.02 | 5.87 ± 6.59 | 18.43 ± 12.79 | 10.69 ± 10.69 | 0.004 |
REM—Rapid eye movement; AHI—Apnea Hypopnea Index; PLMSi—Periodic limbs movement during sleep index.
Figure 3Apnea hypopnea index changes between high- and low-ketone groups. Apnea hypopnea indexes in the high-ketone group showed the tendency to improved changes, compared with those in the low-ketone group.